RxSight, Inc. to Present at the SVB Leerink Global Healthcare Conference
04 February 2022 - 8:05AM
RxSight, Inc., an ophthalmic medical device company dedicated to
improving the vision of patients following cataract surgery, today
announced plans to participate in the upcoming virtual SVB Leerink
Global Healthcare Conference.
RxSight’s management is scheduled to participate in
a fireside chat Thursday, February 17, 2022, at 12:40pm PT / 3:40pm
ET. Interested parties may access a live and archived webcast of
the presentation on the “Investors” section of the company’s
website at: https://investors.rxsight.com/.
About RxSight, Inc.RxSight, Inc. is a
commercial-stage medical technology company dedicated to improving
the vision of patients following cataract surgery. The RxSight®
Light Adjustable Lens system, comprised of the RxSight Light
Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and
accessories, is the first and only commercially available
intraocular lens (IOL) technology that enables doctors to customize
and optimize visual acuity for patients after cataract surgery. The
LAL now features ActivShield™ technology, a revolutionary UV
protection layer built into the lens. Additional information about
RxSight can be found at www.rxsight.com.
Investor Relations Contact:Philip Taylor
Gilmartin Group415.937.5406IR@rxsight.com
Company Contact:Shelley ThunenRxSight,
Inc.949-521-7830IR@rxsight.com
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jun 2024 to Jul 2024
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jul 2023 to Jul 2024